FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

428159003: Ambrisentan (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2688959013 Ambrisentan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2694170014 Ambrisentan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56921000195115 ambrisentan it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
190211000077118 ambrisentan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
72001000195110 Ambrisentan de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ambrisentan (substance) Is a Pyrimidine and/or pyrimidine derivative true Inferred relationship Some
Ambrisentan (substance) Is a Respiratory system agent (substance) true Inferred relationship Some
Ambrisentan (substance) Is a Endothelin receptor antagonist true Inferred relationship Some
Ambrisentan (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Endothelin receptor antagonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ambrisentan 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ambrisentan (substance) Inferred relationship Some
Ambrisentan 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ambrisentan (substance) Inferred relationship Some
Product containing ambrisentan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ambrisentan (substance) Inferred relationship Some 1
Product containing only ambrisentan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ambrisentan (substance) Inferred relationship Some 1
Product containing only ambrisentan in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ambrisentan (substance) Inferred relationship Some 1
Ambrisentan therapy Direct substance True Ambrisentan (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start